Work

Post-Transplant Cyclophosphamide (PTCy) Is Associated with Superior Gvhd-Free, Relapse-Free Survival (GRFS) in HLA-Mismatched Unrelated Donor (MMUD) Hematopoietic Cell Transplantation

Year: 2022

Type: article

Source: Transplantation and Cellular Therapy

DOI: 10.1016/s2666-6367(22)00566-8

Authors: Antonio M. Jimenez Jimenez, Miguel-Angel Perales, Sean M. Devlin, Samantha Brown, Lazaros J. Lekakis, Craig S. Sauter, Denise Pereira, Trent P Wang, Doris M. Ponce, Amer Beitinjaneh, Stephanie Chinapen, Mark Goodman, Krishna V. Komanduri, Brian C. Shaffer

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650

OpenAlex ID: W4221015373

FWCI:

Cites:

Cited by:

Related to: 10